Chapter 8. Immunotherapeutic Strategies against Cancer using Listeria monocytogenes as a Vector for Tumor Antigens

  1. Rimas Orentas PhD2,
  2. James W. Hodge PhD3 and
  3. Bryon D. Johnson PhD4
  1. Nicholas C. Souders PhD,
  2. Thorsten Verch PhD and
  3. Yvonne Paterson PhD

Published Online: 1 MAR 2007

DOI: 10.1002/9780470170113.ch8

Cancer Vaccines and Tumor Immunity

Cancer Vaccines and Tumor Immunity

How to Cite

Souders, N. C., Verch, T. and Paterson, Y. (2008) Immunotherapeutic Strategies against Cancer using Listeria monocytogenes as a Vector for Tumor Antigens, in Cancer Vaccines and Tumor Immunity (eds R. Orentas, J. W. Hodge and B. D. Johnson), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9780470170113.ch8

Editor Information

  1. 2

    Departments of Pediatrics, Medicine, Microbiology and Molecular Genetics, Medical College of Wisconsin and the Children's Research Institute, Children's Hospital of Wisconsin, Milwaukee, WI, USA

  2. 3

    Department of Medical Biology, University of Tennessee Medical Center and Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

  3. 4

    Department of Pediatrics, Medical College of Wisconsin and the Children's Research Institute, Children's Hospital of Wisconsin., Milwaukee, WI, USA

Author Information

  1. Department of Microbiology, University of Pennsylvania, Philadelphia, PA, USA

Publication History

  1. Published Online: 1 MAR 2007
  2. Published Print: 22 JAN 2008

ISBN Information

Print ISBN: 9780470074749

Online ISBN: 9780470170113

SEARCH

Keywords:

  • Listeria monocytogenes - tumor antigen vaccine vector;
  • Listeria- based cancer vaccines;
  • cervical cancer vaccine, LM-LLOE7

Summary

This chapter contains sections titled:

  • Introduction

  • Live Recombinant Vaccine Vectors

  • Safety Concerns

  • Closing Remarks

  • References